A recent study conducted at University Hospitals Connor Whole Health has evaluated a Reiki program designed for outpatients ...

Me, a major company providing direct-to-consumer genetic testing, has been struggling financially since late 2023. In ...

The moves keep happening at the Winter Meetings, as FanSided’s Robert Murray is reporting that the Texas Rangers are bringing back right-hander Nathan Eovaldi on a three-year pact worth $75 million.

DALLAS — Amid the Juan Soto fallout, Brian Cashman pledged a swift pivot to Plan B, and he seemed especially eager to do so ...

This manuscript represents a fundamental contribution demonstrating that fentanyl-induced respiratory depression can be reversed with a peripherally-restricted mu opioid receptor antagonist. The paper ...

What is Guillain-Barré syndrome? Guillain-Barré syndrome (GBS) is also called acute inflammatory demyelinating polyradiculoneuropathy (AIDP). It's a neurological disorder in which the body's immune ...

(Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced the opening of Ntrust-2 to enrollment and the IND clearance for an ...

MeiraGTx Holdings plc sees a stock surge after positive Parkinson's disease data and strategic partnerships, showing growth ...

Hansa Biopharma, "Hansa" and Genethon, a pioneer and a leader in gene therapy research and development for rare genetic diseases, today announced initiation of GNT-018-IDES, a Phase 2 trial in ...

Lung Disease Therapeutics Market. The global lung disease therapeutics market is on an impressive growth trajectory, ...

Atsena Therapeutics and Nippon Shinyaku have formed an exclusive licensing agreement for ATSN-101, a gene therapy for Leber congenital amaurosis (LCA1). Nippon Shinyaku will commercialize ATSN-101 in ...

Although research on CBD is still in its early stages, people are increasingly using it as an alternative treatment for various health conditions, including inflammation. Some research suggests ...